Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system

Molecular Cancer Therapeutics

Volumn 8, Issue 11, 2009, Pages 3140-3150

  Foti, Carmela ^a   Florean, Cristina ^a   Pezzutto, Antonio ^a   Roncaglia, Paola ^b   Tomasella, Andrea ^a   Gustincich, Stefano ^b   Brancolini, Claudio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b SISSA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CASPASE; COLLAGEN TYPE 4; FIBRONECTIN; G 5; GLUTATHIONE; PROTEASOME INHIBITOR; PROTEIN MCL 1; PROTEIN NOXA; TENASCIN; UBIQUITIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; GLIOBLASTOMA; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BORONIC ACIDS; CASPASES; CELL DEATH; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GLIOBLASTOMA; GLUTATHIONE; HUMANS; MICROARRAY ANALYSIS; NECROSIS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRANS; PYRAZINES; SULFHYDRYL COMPOUNDS; UBIQUITIN;

EID: 70949102233     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-09-0431     Document Type: Article

References (41)

1. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007;21:2683-2710 (Pubitemid 350070717)
2. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002;2:616-626 (Pubitemid 37328928)
3. Demarchi F, Brancolini C. Altering protein turnover in tumor cells: new opportunities for anti-cancer therapies. Drug Resist Updat 2005; 8:359-368 (Pubitemid 43358059)
4. Brancolini C. Inhibitors of the ubiquitin-proteasome system and the cell death machinery: how many pathways are activated? Curr Mol Pharm 2008;1:24-37.
5. Love KR, Catic A, Schlieker C, Ploegh HL. Mechanisms, biology and inhibitors of deubiquitinating enzymes. Nat Chem Biol 2007;3: 697-705. (Pubitemid 47609116)
6. Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim. Biophys Acta 2004;1695:189-207.
7. Kirkin V, Dikic I. Role of ubiquitin- and Ubl-binding proteins in cell signaling. Curr Opin Cell Biol 2007;19:199-205. (Pubitemid 46386400)
8. Aleo E, Henderson CJ, Fontanini A, Solazzo B, Brancolini C. Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. Cancer Res 2006;66:9235-9244 (Pubitemid 44521145)
9. Mullally JE, Fitzpatrick FA. Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death. Mol Pharmacol 2002;62:351-358
10. Nicholson B, Leach CA, Goldenberg SJ, et al. Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities. Protein Sci 2008; 17:1035-1043 (Pubitemid 351749209)
11. Fontanini A, Foti C, Potu H, et al. The isopeptidase inhibitor G5 triggers a caspase-independent necrotic death in cells resistant to apoptosis: a comparative study with the proteasome inhibitor bortezomib. J Biol Chem 2009;284:8369-8381
12. Henderson CJ, Aleo E, Fontanini A, Maestro R, Paroni G, Brancolini C. Caspase activation and apoptosis in response to proteasome inhibitors. Cell Death Differ 2005;12:1240-1254 (Pubitemid 41195112)
13. Opel D, Westhoff MA, Bender A, Braun V, Debatin KM, Fulda S. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res 2008; 68:6271-6280
14. Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003; 10:76-100. (Pubitemid 36511834)
15. Batista LF, Roos WP, Christmann M, Menck CF, Kaina B. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc,dd b2, and DNA double-strand breaks. Cancer Res 2007;67:11886-11895
16. Li A, Walling J, Kotliarov Y, et al. Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol Cancer Res 2008;6:21-30.
17. Olopade OI, Jenkins RB, Ransom DT, et al. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 1992;52:2523-2529
18. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
19. Dickinson DA, Levonen AL, Moellering DR, et al. Human glutamate cysteine ligase gene regulation through the electrophile response element. Free Radic Biol Med 2004;37:1152-1159
20. Troyano A, Fernández C, Sancho P, De Blas E, Aller P. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U- 937 human promonocytic cells. The role of intracellular oxidation. J Biol Chem 2001;276:47107-47115
21. Syng-Ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 2004;3:1101-1108 (Pubitemid 39295007)
22. Griffith OW, Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 1979;254:7558-7560 (Pubitemid 10230219)
23. Di Stefano A, Frosali S, Leonini A, et al. GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells. Biochim Biophys Acta 2006;1763:214-225
24. Vercammen D, Beyaert R, Denecker G, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998;187:1477-1485 (Pubitemid 28215406)
25. Wu YT, Tan HL, Huang Q, et al. Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy 2008;4:457-466 (Pubitemid 351705142)
26. Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 2007;32:37-43. (Pubitemid 46043552)
27. Zong WX, Thompson CB. Necrotic death as a cell fate. Genes Dev 2006;20:1-15.
28. Hitomi J, Christofferson DE, Ng A, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008;135:1311-1323
29. Yin D, Zhou H, Kumagai T, et al. Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). Oncogene 2005;24:344-354 (Pubitemid 40188583)
30. La Ferla-Bruhl K, Westhoff MA, Karl S, et al. NF-kB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. Oncogene 2007;26:571-582 (Pubitemid 46160970)
31. Fernandes RS, Cotter TG. Apoptosis or necrosis: intracellular levels of glutathione influence the mode of cell death. Biochem. Pharmacol 1994; 48:675-681
32. Chen D, Chan R, Waxman S, Jing Y. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors. Cancer Res 2006;66:11416-11423 (Pubitemid 46009973)
33. Anathy V, Aesif SW, Guala AS, et al. Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas. J Cell Biol 2009;184:241-252
34. Ljubimova JY, Lakhter AJ, Loksh A, et al. Overexpression of α4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res 2001;61:5601-5610 (Pubitemid 32694948)
35. Freije WA, Castro-Vargas FE, Fang Z, et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res 2004;64:6503-6510 (Pubitemid 39297907)
36. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006;9:157-173 (Pubitemid 43357943)
37. Tso CL, Freije WA, Day A, et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res 2006;66:159-167 (Pubitemid 43166021)
38. Tso CL, Shintaku P, Chen J, et al. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 2006;4:607-619 (Pubitemid 44497214)
39. Huang W, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo A, Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res 2001;61:8586-8594 (Pubitemid 33131143)
40. Belkaid A, Fortier S, Cao J, Borhane A. Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision. Neoplasia 2007;9:332-340
41. Chaigne-Delalande B, Guidicelli G, Couzi L, et al. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal. J Immunol 2008;181:7630-7638